Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000110

Chief Financial Officer sold 3,477 shares at an average $21.45 ($74,576)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-01 Sale : show line 1 in the form 10b5-1 −3,377 $21.43 $72,354 51,102 D
2024-08-01 Sale : show line 2 in the form 10b5-1 −100 $22.22 $2,222 51,002 D
Open-market sales · 3,477 sh · avg $21.45 · $74,576
Loading xslF345X05/wk-form4_1722553573.xml…